Cooperative-Agreement
Cooperative-Agreement funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-AR-27-002: HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
The NIH HEAL Initiative seeks a U24 Data Coordination and Integration Center to harmonize and integrate pain-related datasets, including INTERACT consortium outputs, to support evidence-driven pain research and secondary analysis.
RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.
RFA-CA-27-016: The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
This closed NCI NOFO sought Lead Academic Organizations for the Experimental Therapeutics Clinical Trials Network, using a UM1 cooperative agreement to design, conduct, monitor, and analyze early-phase trials of DCTD/CTEP-IND cancer agents.
RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
The National Cancer Institute's RFA-CA-27-021 supports continued operations and improvement of existing, widely adopted informatics tools and resources for cancer research, with awards capped at $600,000 in direct costs per year for up to five years.
RFA-DE-27-002: Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
NIH Notice of Funding Opportunity for one U24 Resource Center and associated Interdisciplinary Translational Projects to advance tissue engineering and regenerative medicine products through preclinical development toward clinical adoption.
RFA-FD-25-007: Laboratory Flexible Funding Model (LFFM)
FDA's Laboratory Flexible Funding Model Cooperative Agreement supports state and public laboratories to expand food safety and food defense testing capacity through structured analytical tracks in microbiology, chemistry, and radiochemistry.
RFA-JG-26-034: Enhancing Understanding and Preparedness for Public Health Threats Through Research in Kenya
A CDC cooperative agreement to support research, implementation science, and public-health evaluations in Kenya across four required priority areas, while strengthening local research capacity and systems for disease detection, prevention, and response.
RFA-MH-26-120: BRAIN Initiative Reagent Resources for Brain Cell Type-Specific Access (U24)
NIH’s BRAIN Initiative cooperative agreement funds facilities that produce and distribute brain cell type-specific access and manipulation reagents for neuroscience users.
RFA-MH-27-205: Single Source: Accelerating Medicines Partnership Schizophrenia DPACC
The National Institute of Mental Health published a closed single-source U24 cooperative agreement for Brigham and Women's Hospital to continue the AMP Schizophrenia Data Processing, Analysis, and Coordination Center. The FY2027 cycle had one $5,000,000 award and a June 9, 2026 application deadline.
RFA-NS-25-017: BRAIN Initiative—Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System
Historical NIH BRAIN Initiative U01 funding opportunity for optimizing instrumentation and device technologies for neural recording and modulation. The final receipt date was June 15, 2026, and the NOFO expired June 16, 2026; no successor cycle is announced on the official notices reviewed.